中文名 | 1-Boc-4-氰基呱啶-4-甲酸 |
---|---|
英文名 | 4-cyano-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-4-carboxylic acid |
英文别名 |
N-BOC-4-CYANOPIPERIDINE-4-CARBOXYLIC ACID
4-cyano-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester 1-tert-butoxycarbonyl-4-cyano-4-piperidinecarboxylic acid |
分子式 | C12H18N2O4 |
---|---|
分子量 | 254.28200 |
精确质量 | 254.12700 |
PSA | 90.63000 |
LogP | 1.54978 |
储存条件 | 2-8°C,密封,干燥 |
海关编码 | 2933399090 |
---|
~97% 495415-34-4 |
文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH:ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED; ASTRAZENECA AB Patent: WO2008/75110 A1, 2008 ; Location in patent: Page/Page column 138-139 ; WO 2008/075110 A1 |
海关编码 | 2933399090 |
---|---|
中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |